Success for non-Hodgkin lymphoma drug

Scientists in Houston, America have developed a new chemotherapy drug to fight non-Hodgkin lymphoma and chronic lymphocytic leukaemia.

The drug, which was being investigated for its potency against the two different types of cancer has been found to be effective in about one-third of the 58 patients who participated in the study. Read more

Our awards and nominations